nodes	percent_of_prediction	percent_of_DWPC	metapath
Lapatinib—CYP2C19—epilepsy syndrome	0.147	0.654	CbGaD
Lapatinib—ABCB1—epilepsy syndrome	0.0776	0.346	CbGaD
Lapatinib—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.0196	0.041	CbGbCtD
Lapatinib—CYP2C8—Trimethadione—epilepsy syndrome	0.0175	0.0367	CbGbCtD
Lapatinib—CYP2C8—Fosphenytoin—epilepsy syndrome	0.0165	0.0345	CbGbCtD
Lapatinib—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.0158	0.0331	CbGbCtD
Lapatinib—CYP2C19—Felbamate—epilepsy syndrome	0.0147	0.0308	CbGbCtD
Lapatinib—CYP2C19—Trimethadione—epilepsy syndrome	0.0147	0.0308	CbGbCtD
Lapatinib—ABCB1—Levetiracetam—epilepsy syndrome	0.014	0.0292	CbGbCtD
Lapatinib—CYP2C19—Fosphenytoin—epilepsy syndrome	0.0138	0.0289	CbGbCtD
Lapatinib—CYP3A5—Carbamazepine—epilepsy syndrome	0.0123	0.0258	CbGbCtD
Lapatinib—CYP2C19—Clobazam—epilepsy syndrome	0.012	0.0251	CbGbCtD
Lapatinib—CYP2C8—Carbamazepine—epilepsy syndrome	0.0119	0.0248	CbGbCtD
Lapatinib—CYP2C8—Primidone—epilepsy syndrome	0.0111	0.0231	CbGbCtD
Lapatinib—CYP3A5—Phenytoin—epilepsy syndrome	0.0111	0.0231	CbGbCtD
Lapatinib—CYP2C8—Phenytoin—epilepsy syndrome	0.0106	0.0222	CbGbCtD
Lapatinib—CYP2C19—Carbamazepine—epilepsy syndrome	0.00994	0.0208	CbGbCtD
Lapatinib—CYP2C8—Propofol—epilepsy syndrome	0.00991	0.0207	CbGbCtD
Lapatinib—CYP3A5—Phenobarbital—epilepsy syndrome	0.00985	0.0206	CbGbCtD
Lapatinib—CYP3A5—Midazolam—epilepsy syndrome	0.00972	0.0203	CbGbCtD
Lapatinib—ABCB1—Clobazam—epilepsy syndrome	0.00968	0.0202	CbGbCtD
Lapatinib—CYP2C8—Phenobarbital—epilepsy syndrome	0.00948	0.0198	CbGbCtD
Lapatinib—CYP3A5—Diazepam—epilepsy syndrome	0.00934	0.0195	CbGbCtD
Lapatinib—ABCB1—Lamotrigine—epilepsy syndrome	0.00932	0.0195	CbGbCtD
Lapatinib—CYP2C19—Primidone—epilepsy syndrome	0.00928	0.0194	CbGbCtD
Lapatinib—CYP2C8—Diazepam—epilepsy syndrome	0.00898	0.0188	CbGbCtD
Lapatinib—CYP2C19—Phenytoin—epilepsy syndrome	0.00892	0.0186	CbGbCtD
Lapatinib—CYP2C19—Propofol—epilepsy syndrome	0.00832	0.0174	CbGbCtD
Lapatinib—ABCB1—Carbamazepine—epilepsy syndrome	0.00802	0.0168	CbGbCtD
Lapatinib—CYP2C19—Phenobarbital—epilepsy syndrome	0.00795	0.0166	CbGbCtD
Lapatinib—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00765	0.016	CbGbCtD
Lapatinib—CYP2C19—Diazepam—epilepsy syndrome	0.00754	0.0158	CbGbCtD
Lapatinib—CYP3A5—Valproic Acid—epilepsy syndrome	0.00736	0.0154	CbGbCtD
Lapatinib—CYP2C19—Zonisamide—epilepsy syndrome	0.00736	0.0154	CbGbCtD
Lapatinib—ABCB1—Phenytoin—epilepsy syndrome	0.0072	0.015	CbGbCtD
Lapatinib—CYP3A4—Trimethadione—epilepsy syndrome	0.00712	0.0149	CbGbCtD
Lapatinib—CYP3A4—Felbamate—epilepsy syndrome	0.00712	0.0149	CbGbCtD
Lapatinib—CYP2C8—Valproic Acid—epilepsy syndrome	0.00708	0.0148	CbGbCtD
Lapatinib—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00669	0.014	CbGbCtD
Lapatinib—ABCB1—Phenobarbital—epilepsy syndrome	0.00641	0.0134	CbGbCtD
Lapatinib—ABCB1—Midazolam—epilepsy syndrome	0.00632	0.0132	CbGbCtD
Lapatinib—ABCB1—Diazepam—epilepsy syndrome	0.00608	0.0127	CbGbCtD
Lapatinib—CYP3A4—Clonazepam—epilepsy syndrome	0.00605	0.0127	CbGbCtD
Lapatinib—CYP2C19—Valproic Acid—epilepsy syndrome	0.00594	0.0124	CbGbCtD
Lapatinib—CYP3A4—Clobazam—epilepsy syndrome	0.0058	0.0121	CbGbCtD
Lapatinib—CYP2C19—Topiramate—epilepsy syndrome	0.00536	0.0112	CbGbCtD
Lapatinib—CYP3A4—Rufinamide—epilepsy syndrome	0.00493	0.0103	CbGbCtD
Lapatinib—CYP3A4—Carbamazepine—epilepsy syndrome	0.00481	0.0101	CbGbCtD
Lapatinib—CYP3A4—Primidone—epilepsy syndrome	0.00449	0.00938	CbGbCtD
Lapatinib—CYP3A4—Phenytoin—epilepsy syndrome	0.00431	0.00901	CbGbCtD
Lapatinib—CYP3A4—Propofol—epilepsy syndrome	0.00402	0.00841	CbGbCtD
Lapatinib—CYP3A4—Phenobarbital—epilepsy syndrome	0.00384	0.00803	CbGbCtD
Lapatinib—CYP3A4—Acetazolamide—epilepsy syndrome	0.00384	0.00803	CbGbCtD
Lapatinib—CYP3A4—Midazolam—epilepsy syndrome	0.00379	0.00792	CbGbCtD
Lapatinib—CYP3A4—Diazepam—epilepsy syndrome	0.00364	0.00762	CbGbCtD
Lapatinib—CYP3A4—Zonisamide—epilepsy syndrome	0.00356	0.00743	CbGbCtD
Lapatinib—CYP3A4—Valproic Acid—epilepsy syndrome	0.00287	0.006	CbGbCtD
Lapatinib—CYP3A4—Topiramate—epilepsy syndrome	0.00259	0.00542	CbGbCtD
Lapatinib—PIK3C2B—telencephalon—epilepsy syndrome	0.00171	0.0406	CbGeAlD
Lapatinib—ERBB4—brainstem—epilepsy syndrome	0.0015	0.0356	CbGeAlD
Lapatinib—ERBB4—forebrain—epilepsy syndrome	0.00145	0.0343	CbGeAlD
Lapatinib—TAP1—medulla oblongata—epilepsy syndrome	0.00143	0.034	CbGeAlD
Lapatinib—PIK3C2B—medulla oblongata—epilepsy syndrome	0.00134	0.0319	CbGeAlD
Lapatinib—ERBB4—telencephalon—epilepsy syndrome	0.00133	0.0316	CbGeAlD
Lapatinib—TAP1—midbrain—epilepsy syndrome	0.00131	0.0311	CbGeAlD
Lapatinib—TAP1—spinal cord—epilepsy syndrome	0.00128	0.0303	CbGeAlD
Lapatinib—PI4KB—telencephalon—epilepsy syndrome	0.00125	0.0296	CbGeAlD
Lapatinib—PIK3C2B—midbrain—epilepsy syndrome	0.00123	0.0292	CbGeAlD
Lapatinib—PIK3C2B—spinal cord—epilepsy syndrome	0.0012	0.0284	CbGeAlD
Lapatinib—EGFR—telencephalon—epilepsy syndrome	0.00113	0.0268	CbGeAlD
Lapatinib—PIK3C2B—head—epilepsy syndrome	0.00107	0.0253	CbGeAlD
Lapatinib—ERBB4—medulla oblongata—epilepsy syndrome	0.00105	0.0248	CbGeAlD
Lapatinib—TAP1—cerebellum—epilepsy syndrome	0.00101	0.024	CbGeAlD
Lapatinib—PIK3C2B—nervous system—epilepsy syndrome	0.00101	0.024	CbGeAlD
Lapatinib—PI4KB—medulla oblongata—epilepsy syndrome	0.000979	0.0232	CbGeAlD
Lapatinib—PIK3C2B—central nervous system—epilepsy syndrome	0.000972	0.0231	CbGeAlD
Lapatinib—ERBB4—midbrain—epilepsy syndrome	0.000955	0.0227	CbGeAlD
Lapatinib—PIK3C2B—cerebellum—epilepsy syndrome	0.00095	0.0226	CbGeAlD
Lapatinib—ERBB4—spinal cord—epilepsy syndrome	0.000932	0.0221	CbGeAlD
Lapatinib—PIK3C2B—Protriptyline—Carbamazepine—epilepsy syndrome	0.000922	0.363	CbGdCrCtD
Lapatinib—PI4KB—midbrain—epilepsy syndrome	0.000895	0.0212	CbGeAlD
Lapatinib—PI4KB—spinal cord—epilepsy syndrome	0.000873	0.0207	CbGeAlD
Lapatinib—ERBB2—head—epilepsy syndrome	0.000829	0.0197	CbGeAlD
Lapatinib—ERBB4—head—epilepsy syndrome	0.000829	0.0197	CbGeAlD
Lapatinib—TAP1—brain—epilepsy syndrome	0.000822	0.0195	CbGeAlD
Lapatinib—ERBB2—nervous system—epilepsy syndrome	0.000785	0.0186	CbGeAlD
Lapatinib—ERBB4—nervous system—epilepsy syndrome	0.000785	0.0186	CbGeAlD
Lapatinib—PI4KB—head—epilepsy syndrome	0.000776	0.0184	CbGeAlD
Lapatinib—PIK3C2B—brain—epilepsy syndrome	0.000772	0.0183	CbGeAlD
Lapatinib—ERBB4—central nervous system—epilepsy syndrome	0.000756	0.0179	CbGeAlD
Lapatinib—ERBB2—central nervous system—epilepsy syndrome	0.000756	0.0179	CbGeAlD
Lapatinib—ERBB4—cerebellum—epilepsy syndrome	0.000739	0.0175	CbGeAlD
Lapatinib—ERBB2—cerebellum—epilepsy syndrome	0.000739	0.0175	CbGeAlD
Lapatinib—PI4KB—nervous system—epilepsy syndrome	0.000736	0.0175	CbGeAlD
Lapatinib—PI4KB—central nervous system—epilepsy syndrome	0.000708	0.0168	CbGeAlD
Lapatinib—PI4KB—cerebellum—epilepsy syndrome	0.000692	0.0164	CbGeAlD
Lapatinib—PIK3C2B—Bortezomib—Lacosamide—epilepsy syndrome	0.000642	0.253	CbGdCrCtD
Lapatinib—EGFR—cerebellum—epilepsy syndrome	0.000627	0.0149	CbGeAlD
Lapatinib—ERBB2—brain—epilepsy syndrome	0.0006	0.0142	CbGeAlD
Lapatinib—ERBB4—brain—epilepsy syndrome	0.0006	0.0142	CbGeAlD
Lapatinib—PI4KB—brain—epilepsy syndrome	0.000562	0.0133	CbGeAlD
Lapatinib—ERBB2—Bortezomib—Lacosamide—epilepsy syndrome	0.000529	0.208	CbGdCrCtD
Lapatinib—EGFR—brain—epilepsy syndrome	0.000509	0.0121	CbGeAlD
Lapatinib—Gefitinib—ABCG2—epilepsy syndrome	0.000477	0.31	CrCbGaD
Lapatinib—PIK3C2B—Niclosamide—Clonazepam—epilepsy syndrome	0.000445	0.175	CbGdCrCtD
Lapatinib—Gefitinib—CYP2C19—epilepsy syndrome	0.000375	0.244	CrCbGaD
Lapatinib—Gefitinib—CYP2D6—epilepsy syndrome	0.000278	0.181	CrCbGaD
Lapatinib—Gefitinib—ALB—epilepsy syndrome	0.000208	0.135	CrCbGaD
Lapatinib—Gefitinib—ABCB1—epilepsy syndrome	0.000199	0.129	CrCbGaD
Lapatinib—ABCB1—forebrain—epilepsy syndrome	0.000189	0.00447	CbGeAlD
Lapatinib—ABCB1—telencephalon—epilepsy syndrome	0.000173	0.00411	CbGeAlD
Lapatinib—CYP2C8—brain—epilepsy syndrome	0.000163	0.00387	CbGeAlD
Lapatinib—CYP3A4—nervous system—epilepsy syndrome	0.000145	0.00343	CbGeAlD
Lapatinib—CYP3A4—central nervous system—epilepsy syndrome	0.000139	0.0033	CbGeAlD
Lapatinib—ABCB1—medulla oblongata—epilepsy syndrome	0.000136	0.00323	CbGeAlD
Lapatinib—ABCB1—midbrain—epilepsy syndrome	0.000124	0.00295	CbGeAlD
Lapatinib—ABCB1—spinal cord—epilepsy syndrome	0.000121	0.00288	CbGeAlD
Lapatinib—Infestation—Topiramate—epilepsy syndrome	0.00011	0.000805	CcSEcCtD
Lapatinib—Infestation NOS—Topiramate—epilepsy syndrome	0.00011	0.000805	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	0.000109	0.0008	CcSEcCtD
Lapatinib—Abdominal pain—Clonazepam—epilepsy syndrome	0.000109	0.000799	CcSEcCtD
Lapatinib—Fatigue—Lamotrigine—epilepsy syndrome	0.000109	0.000798	CcSEcCtD
Lapatinib—Cardiac disorder—Gabapentin—epilepsy syndrome	0.000109	0.000797	CcSEcCtD
Lapatinib—Palpitations—Valproic Acid—epilepsy syndrome	0.000109	0.000797	CcSEcCtD
Lapatinib—Pruritus—Vigabatrin—epilepsy syndrome	0.000109	0.000795	CcSEcCtD
Lapatinib—Asthenia—Diazepam—epilepsy syndrome	0.000109	0.000794	CcSEcCtD
Lapatinib—Constipation—Lamotrigine—epilepsy syndrome	0.000108	0.000792	CcSEcCtD
Lapatinib—Nausea—Acetazolamide—epilepsy syndrome	0.000108	0.000791	CcSEcCtD
Lapatinib—ABCB1—head—epilepsy syndrome	0.000108	0.00256	CbGeAlD
Lapatinib—Abdominal pain—Oxcarbazepine—epilepsy syndrome	0.000108	0.000789	CcSEcCtD
Lapatinib—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000108	0.000789	CcSEcCtD
Lapatinib—Neuropathy peripheral—Topiramate—epilepsy syndrome	0.000108	0.000789	CcSEcCtD
Lapatinib—Back pain—Pregabalin—epilepsy syndrome	0.000108	0.000789	CcSEcCtD
Lapatinib—Cough—Valproic Acid—epilepsy syndrome	0.000108	0.000787	CcSEcCtD
Lapatinib—Vomiting—Propofol—epilepsy syndrome	0.000108	0.000787	CcSEcCtD
Lapatinib—Stomatitis—Topiramate—epilepsy syndrome	0.000107	0.000784	CcSEcCtD
Lapatinib—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	0.000107	0.000784	CcSEcCtD
Lapatinib—Pruritus—Diazepam—epilepsy syndrome	0.000107	0.000783	CcSEcCtD
Lapatinib—Rash—Propofol—epilepsy syndrome	0.000107	0.00078	CcSEcCtD
Lapatinib—Dermatitis—Propofol—epilepsy syndrome	0.000107	0.000779	CcSEcCtD
Lapatinib—Immune system disorder—Gabapentin—epilepsy syndrome	0.000106	0.000776	CcSEcCtD
Lapatinib—Headache—Propofol—epilepsy syndrome	0.000106	0.000775	CcSEcCtD
Lapatinib—Mediastinal disorder—Gabapentin—epilepsy syndrome	0.000106	0.000774	CcSEcCtD
Lapatinib—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000106	0.000773	CcSEcCtD
Lapatinib—Vomiting—Midazolam—epilepsy syndrome	0.000105	0.00077	CcSEcCtD
Lapatinib—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000105	0.000769	CcSEcCtD
Lapatinib—Asthenia—Felbamate—epilepsy syndrome	0.000105	0.000769	CcSEcCtD
Lapatinib—Arthralgia—Valproic Acid—epilepsy syndrome	0.000105	0.000768	CcSEcCtD
Lapatinib—Myalgia—Valproic Acid—epilepsy syndrome	0.000105	0.000768	CcSEcCtD
Lapatinib—Rash—Midazolam—epilepsy syndrome	0.000104	0.000763	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	0.000104	0.000762	CcSEcCtD
Lapatinib—Dermatitis—Midazolam—epilepsy syndrome	0.000104	0.000762	CcSEcCtD
Lapatinib—Vomiting—Levetiracetam—epilepsy syndrome	0.000104	0.00076	CcSEcCtD
Lapatinib—Epistaxis—Topiramate—epilepsy syndrome	0.000104	0.000759	CcSEcCtD
Lapatinib—Alopecia—Gabapentin—epilepsy syndrome	0.000104	0.000759	CcSEcCtD
Lapatinib—Headache—Midazolam—epilepsy syndrome	0.000104	0.000758	CcSEcCtD
Lapatinib—Pruritus—Felbamate—epilepsy syndrome	0.000104	0.000758	CcSEcCtD
Lapatinib—Abdominal pain—Carbamazepine—epilepsy syndrome	0.000104	0.000758	CcSEcCtD
Lapatinib—Diarrhoea—Diazepam—epilepsy syndrome	0.000104	0.000757	CcSEcCtD
Lapatinib—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.000104	0.000757	CcSEcCtD
Lapatinib—Rash—Levetiracetam—epilepsy syndrome	0.000103	0.000754	CcSEcCtD
Lapatinib—Anaemia—Pregabalin—epilepsy syndrome	0.000103	0.000753	CcSEcCtD
Lapatinib—Dermatitis—Levetiracetam—epilepsy syndrome	0.000103	0.000753	CcSEcCtD
Lapatinib—Asthenia—Zonisamide—epilepsy syndrome	0.000103	0.000752	CcSEcCtD
Lapatinib—Mental disorder—Gabapentin—epilepsy syndrome	0.000103	0.000752	CcSEcCtD
Lapatinib—Headache—Levetiracetam—epilepsy syndrome	0.000102	0.000749	CcSEcCtD
Lapatinib—ABCB1—nervous system—epilepsy syndrome	0.000102	0.00243	CbGeAlD
Lapatinib—Malnutrition—Gabapentin—epilepsy syndrome	0.000102	0.000748	CcSEcCtD
Lapatinib—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000102	0.000745	CcSEcCtD
Lapatinib—Pruritus—Zonisamide—epilepsy syndrome	0.000101	0.000742	CcSEcCtD
Lapatinib—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000101	0.00074	CcSEcCtD
Lapatinib—Anaphylactic shock—Valproic Acid—epilepsy syndrome	0.000101	0.000736	CcSEcCtD
Lapatinib—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000101	0.000736	CcSEcCtD
Lapatinib—Nausea—Propofol—epilepsy syndrome	0.0001	0.000735	CcSEcCtD
Lapatinib—Vomiting—Fosphenytoin—epilepsy syndrome	0.0001	0.000733	CcSEcCtD
Lapatinib—Diarrhoea—Felbamate—epilepsy syndrome	0.0001	0.000733	CcSEcCtD
Lapatinib—Abdominal pain—Lamotrigine—epilepsy syndrome	0.0001	0.000732	CcSEcCtD
Lapatinib—Infection—Valproic Acid—epilepsy syndrome	0.0001	0.000731	CcSEcCtD
Lapatinib—Leukopenia—Pregabalin—epilepsy syndrome	9.98e-05	0.00073	CcSEcCtD
Lapatinib—Rash—Fosphenytoin—epilepsy syndrome	9.94e-05	0.000727	CcSEcCtD
Lapatinib—Dermatitis—Fosphenytoin—epilepsy syndrome	9.93e-05	0.000727	CcSEcCtD
Lapatinib—Asthenia—Clonazepam—epilepsy syndrome	9.91e-05	0.000725	CcSEcCtD
Lapatinib—Back pain—Gabapentin—epilepsy syndrome	9.89e-05	0.000723	CcSEcCtD
Lapatinib—Headache—Fosphenytoin—epilepsy syndrome	9.88e-05	0.000723	CcSEcCtD
Lapatinib—Nervous system disorder—Valproic Acid—epilepsy syndrome	9.87e-05	0.000722	CcSEcCtD
Lapatinib—ABCB1—central nervous system—epilepsy syndrome	9.85e-05	0.00234	CbGeAlD
Lapatinib—Palpitations—Pregabalin—epilepsy syndrome	9.85e-05	0.00072	CcSEcCtD
Lapatinib—Asthenia—Phenytoin—epilepsy syndrome	9.85e-05	0.00072	CcSEcCtD
Lapatinib—Nausea—Midazolam—epilepsy syndrome	9.83e-05	0.000719	CcSEcCtD
Lapatinib—Diarrhoea—Zonisamide—epilepsy syndrome	9.81e-05	0.000718	CcSEcCtD
Lapatinib—Asthenia—Oxcarbazepine—epilepsy syndrome	9.79e-05	0.000716	CcSEcCtD
Lapatinib—Pruritus—Clonazepam—epilepsy syndrome	9.78e-05	0.000715	CcSEcCtD
Lapatinib—Vomiting—Vigabatrin—epilepsy syndrome	9.77e-05	0.000715	CcSEcCtD
Lapatinib—Skin disorder—Valproic Acid—epilepsy syndrome	9.77e-05	0.000715	CcSEcCtD
Lapatinib—Cough—Pregabalin—epilepsy syndrome	9.73e-05	0.000711	CcSEcCtD
Lapatinib—Pruritus—Phenytoin—epilepsy syndrome	9.71e-05	0.00071	CcSEcCtD
Lapatinib—Connective tissue disorder—Topiramate—epilepsy syndrome	9.71e-05	0.00071	CcSEcCtD
Lapatinib—Nausea—Levetiracetam—epilepsy syndrome	9.7e-05	0.00071	CcSEcCtD
Lapatinib—Rash—Vigabatrin—epilepsy syndrome	9.69e-05	0.000709	CcSEcCtD
Lapatinib—Dermatitis—Vigabatrin—epilepsy syndrome	9.68e-05	0.000708	CcSEcCtD
Lapatinib—Pruritus—Oxcarbazepine—epilepsy syndrome	9.66e-05	0.000707	CcSEcCtD
Lapatinib—Hypersensitivity—Carbamazepine—epilepsy syndrome	9.65e-05	0.000706	CcSEcCtD
Lapatinib—ABCB1—cerebellum—epilepsy syndrome	9.63e-05	0.00229	CbGeAlD
Lapatinib—Headache—Vigabatrin—epilepsy syndrome	9.63e-05	0.000704	CcSEcCtD
Lapatinib—Vomiting—Diazepam—epilepsy syndrome	9.62e-05	0.000704	CcSEcCtD
Lapatinib—Anorexia—Valproic Acid—epilepsy syndrome	9.59e-05	0.000702	CcSEcCtD
Lapatinib—Rash—Diazepam—epilepsy syndrome	9.54e-05	0.000698	CcSEcCtD
Lapatinib—Dermatitis—Diazepam—epilepsy syndrome	9.53e-05	0.000697	CcSEcCtD
Lapatinib—Arthralgia—Pregabalin—epilepsy syndrome	9.49e-05	0.000694	CcSEcCtD
Lapatinib—Myalgia—Pregabalin—epilepsy syndrome	9.49e-05	0.000694	CcSEcCtD
Lapatinib—Headache—Diazepam—epilepsy syndrome	9.48e-05	0.000693	CcSEcCtD
Lapatinib—Diarrhoea—Clonazepam—epilepsy syndrome	9.45e-05	0.000692	CcSEcCtD
Lapatinib—Anaemia—Gabapentin—epilepsy syndrome	9.45e-05	0.000691	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	9.42e-05	0.000689	CcSEcCtD
Lapatinib—Asthenia—Carbamazepine—epilepsy syndrome	9.4e-05	0.000688	CcSEcCtD
Lapatinib—Diarrhoea—Phenytoin—epilepsy syndrome	9.39e-05	0.000687	CcSEcCtD
Lapatinib—Nausea—Fosphenytoin—epilepsy syndrome	9.37e-05	0.000685	CcSEcCtD
Lapatinib—Diarrhoea—Oxcarbazepine—epilepsy syndrome	9.34e-05	0.000683	CcSEcCtD
Lapatinib—Hypersensitivity—Lamotrigine—epilepsy syndrome	9.33e-05	0.000682	CcSEcCtD
Lapatinib—Vomiting—Felbamate—epilepsy syndrome	9.31e-05	0.000681	CcSEcCtD
Lapatinib—Pruritus—Carbamazepine—epilepsy syndrome	9.27e-05	0.000678	CcSEcCtD
Lapatinib—Rash—Felbamate—epilepsy syndrome	9.23e-05	0.000676	CcSEcCtD
Lapatinib—Dermatitis—Felbamate—epilepsy syndrome	9.23e-05	0.000675	CcSEcCtD
Lapatinib—Headache—Felbamate—epilepsy syndrome	9.18e-05	0.000671	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	9.17e-05	0.000671	CcSEcCtD
Lapatinib—Cardiac disorder—Topiramate—epilepsy syndrome	9.17e-05	0.000671	CcSEcCtD
Lapatinib—Leukopenia—Gabapentin—epilepsy syndrome	9.15e-05	0.000669	CcSEcCtD
Lapatinib—Nausea—Vigabatrin—epilepsy syndrome	9.13e-05	0.000668	CcSEcCtD
Lapatinib—Vomiting—Zonisamide—epilepsy syndrome	9.12e-05	0.000667	CcSEcCtD
Lapatinib—Insomnia—Valproic Acid—epilepsy syndrome	9.1e-05	0.000666	CcSEcCtD
Lapatinib—Anaphylactic shock—Pregabalin—epilepsy syndrome	9.1e-05	0.000665	CcSEcCtD
Lapatinib—Asthenia—Lamotrigine—epilepsy syndrome	9.08e-05	0.000664	CcSEcCtD
Lapatinib—Rash—Zonisamide—epilepsy syndrome	9.04e-05	0.000661	CcSEcCtD
Lapatinib—Infection—Pregabalin—epilepsy syndrome	9.04e-05	0.000661	CcSEcCtD
Lapatinib—Palpitations—Gabapentin—epilepsy syndrome	9.03e-05	0.000661	CcSEcCtD
Lapatinib—Dermatitis—Zonisamide—epilepsy syndrome	9.03e-05	0.000661	CcSEcCtD
Lapatinib—Nausea—Diazepam—epilepsy syndrome	8.99e-05	0.000657	CcSEcCtD
Lapatinib—Headache—Zonisamide—epilepsy syndrome	8.98e-05	0.000657	CcSEcCtD
Lapatinib—Dyspnoea—Valproic Acid—epilepsy syndrome	8.97e-05	0.000656	CcSEcCtD
Lapatinib—Diarrhoea—Carbamazepine—epilepsy syndrome	8.96e-05	0.000656	CcSEcCtD
Lapatinib—Angiopathy—Topiramate—epilepsy syndrome	8.96e-05	0.000655	CcSEcCtD
Lapatinib—Pruritus—Lamotrigine—epilepsy syndrome	8.96e-05	0.000655	CcSEcCtD
Lapatinib—Immune system disorder—Topiramate—epilepsy syndrome	8.92e-05	0.000653	CcSEcCtD
Lapatinib—Nervous system disorder—Pregabalin—epilepsy syndrome	8.92e-05	0.000652	CcSEcCtD
Lapatinib—Cough—Gabapentin—epilepsy syndrome	8.92e-05	0.000652	CcSEcCtD
Lapatinib—Mediastinal disorder—Topiramate—epilepsy syndrome	8.9e-05	0.000651	CcSEcCtD
Lapatinib—Dyspepsia—Valproic Acid—epilepsy syndrome	8.86e-05	0.000648	CcSEcCtD
Lapatinib—Skin disorder—Pregabalin—epilepsy syndrome	8.83e-05	0.000646	CcSEcCtD
Lapatinib—Vomiting—Clonazepam—epilepsy syndrome	8.78e-05	0.000643	CcSEcCtD
Lapatinib—Decreased appetite—Valproic Acid—epilepsy syndrome	8.75e-05	0.00064	CcSEcCtD
Lapatinib—Alopecia—Topiramate—epilepsy syndrome	8.73e-05	0.000638	CcSEcCtD
Lapatinib—Vomiting—Phenytoin—epilepsy syndrome	8.73e-05	0.000638	CcSEcCtD
Lapatinib—Rash—Clonazepam—epilepsy syndrome	8.71e-05	0.000637	CcSEcCtD
Lapatinib—Dermatitis—Clonazepam—epilepsy syndrome	8.7e-05	0.000637	CcSEcCtD
Lapatinib—Arthralgia—Gabapentin—epilepsy syndrome	8.7e-05	0.000636	CcSEcCtD
Lapatinib—Myalgia—Gabapentin—epilepsy syndrome	8.7e-05	0.000636	CcSEcCtD
Lapatinib—Nausea—Felbamate—epilepsy syndrome	8.7e-05	0.000636	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	8.69e-05	0.000635	CcSEcCtD
Lapatinib—Vomiting—Oxcarbazepine—epilepsy syndrome	8.68e-05	0.000635	CcSEcCtD
Lapatinib—Fatigue—Valproic Acid—epilepsy syndrome	8.67e-05	0.000634	CcSEcCtD
Lapatinib—Anorexia—Pregabalin—epilepsy syndrome	8.67e-05	0.000634	CcSEcCtD
Lapatinib—Diarrhoea—Lamotrigine—epilepsy syndrome	8.66e-05	0.000634	CcSEcCtD
Lapatinib—Headache—Clonazepam—epilepsy syndrome	8.66e-05	0.000633	CcSEcCtD
Lapatinib—Rash—Phenytoin—epilepsy syndrome	8.65e-05	0.000633	CcSEcCtD
Lapatinib—Mental disorder—Topiramate—epilepsy syndrome	8.65e-05	0.000633	CcSEcCtD
Lapatinib—Dermatitis—Phenytoin—epilepsy syndrome	8.65e-05	0.000632	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	8.64e-05	0.000632	CcSEcCtD
Lapatinib—Rash—Oxcarbazepine—epilepsy syndrome	8.61e-05	0.00063	CcSEcCtD
Lapatinib—Constipation—Valproic Acid—epilepsy syndrome	8.6e-05	0.000629	CcSEcCtD
Lapatinib—Dermatitis—Oxcarbazepine—epilepsy syndrome	8.6e-05	0.000629	CcSEcCtD
Lapatinib—Headache—Phenytoin—epilepsy syndrome	8.6e-05	0.000629	CcSEcCtD
Lapatinib—Malnutrition—Topiramate—epilepsy syndrome	8.6e-05	0.000629	CcSEcCtD
Lapatinib—Headache—Oxcarbazepine—epilepsy syndrome	8.55e-05	0.000626	CcSEcCtD
Lapatinib—Nausea—Zonisamide—epilepsy syndrome	8.52e-05	0.000623	CcSEcCtD
Lapatinib—Anaphylactic shock—Gabapentin—epilepsy syndrome	8.34e-05	0.00061	CcSEcCtD
Lapatinib—Vomiting—Carbamazepine—epilepsy syndrome	8.33e-05	0.000609	CcSEcCtD
Lapatinib—Back pain—Topiramate—epilepsy syndrome	8.32e-05	0.000608	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	8.29e-05	0.000606	CcSEcCtD
Lapatinib—Infection—Gabapentin—epilepsy syndrome	8.29e-05	0.000606	CcSEcCtD
Lapatinib—Rash—Carbamazepine—epilepsy syndrome	8.26e-05	0.000604	CcSEcCtD
Lapatinib—Dermatitis—Carbamazepine—epilepsy syndrome	8.25e-05	0.000604	CcSEcCtD
Lapatinib—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	8.23e-05	0.000602	CcSEcCtD
Lapatinib—Insomnia—Pregabalin—epilepsy syndrome	8.23e-05	0.000602	CcSEcCtD
Lapatinib—Nausea—Clonazepam—epilepsy syndrome	8.21e-05	0.0006	CcSEcCtD
Lapatinib—Headache—Carbamazepine—epilepsy syndrome	8.21e-05	0.0006	CcSEcCtD
Lapatinib—Nervous system disorder—Gabapentin—epilepsy syndrome	8.18e-05	0.000598	CcSEcCtD
Lapatinib—Nausea—Phenytoin—epilepsy syndrome	8.15e-05	0.000596	CcSEcCtD
Lapatinib—Dyspnoea—Pregabalin—epilepsy syndrome	8.11e-05	0.000593	CcSEcCtD
Lapatinib—Nausea—Oxcarbazepine—epilepsy syndrome	8.11e-05	0.000593	CcSEcCtD
Lapatinib—Skin disorder—Gabapentin—epilepsy syndrome	8.1e-05	0.000593	CcSEcCtD
Lapatinib—Vomiting—Lamotrigine—epilepsy syndrome	8.05e-05	0.000589	CcSEcCtD
Lapatinib—Rash—Lamotrigine—epilepsy syndrome	7.98e-05	0.000584	CcSEcCtD
Lapatinib—Dermatitis—Lamotrigine—epilepsy syndrome	7.98e-05	0.000583	CcSEcCtD
Lapatinib—Abdominal pain—Valproic Acid—epilepsy syndrome	7.95e-05	0.000582	CcSEcCtD
Lapatinib—Anorexia—Gabapentin—epilepsy syndrome	7.95e-05	0.000582	CcSEcCtD
Lapatinib—Anaemia—Topiramate—epilepsy syndrome	7.95e-05	0.000581	CcSEcCtD
Lapatinib—Headache—Lamotrigine—epilepsy syndrome	7.93e-05	0.00058	CcSEcCtD
Lapatinib—Decreased appetite—Pregabalin—epilepsy syndrome	7.91e-05	0.000578	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	7.85e-05	0.000574	CcSEcCtD
Lapatinib—Fatigue—Pregabalin—epilepsy syndrome	7.84e-05	0.000574	CcSEcCtD
Lapatinib—ABCB1—brain—epilepsy syndrome	7.82e-05	0.00186	CbGeAlD
Lapatinib—Nausea—Carbamazepine—epilepsy syndrome	7.78e-05	0.000569	CcSEcCtD
Lapatinib—Constipation—Pregabalin—epilepsy syndrome	7.78e-05	0.000569	CcSEcCtD
Lapatinib—Leukopenia—Topiramate—epilepsy syndrome	7.7e-05	0.000563	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	7.6e-05	0.000556	CcSEcCtD
Lapatinib—Palpitations—Topiramate—epilepsy syndrome	7.6e-05	0.000556	CcSEcCtD
Lapatinib—Insomnia—Gabapentin—epilepsy syndrome	7.54e-05	0.000552	CcSEcCtD
Lapatinib—Nausea—Lamotrigine—epilepsy syndrome	7.52e-05	0.00055	CcSEcCtD
Lapatinib—Cough—Topiramate—epilepsy syndrome	7.5e-05	0.000549	CcSEcCtD
Lapatinib—Gastrointestinal pain—Pregabalin—epilepsy syndrome	7.44e-05	0.000544	CcSEcCtD
Lapatinib—Dyspnoea—Gabapentin—epilepsy syndrome	7.44e-05	0.000544	CcSEcCtD
Lapatinib—Hypersensitivity—Valproic Acid—epilepsy syndrome	7.41e-05	0.000542	CcSEcCtD
Lapatinib—Dyspepsia—Gabapentin—epilepsy syndrome	7.34e-05	0.000537	CcSEcCtD
Lapatinib—Arthralgia—Topiramate—epilepsy syndrome	7.32e-05	0.000535	CcSEcCtD
Lapatinib—Myalgia—Topiramate—epilepsy syndrome	7.32e-05	0.000535	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	7.27e-05	0.000532	CcSEcCtD
Lapatinib—Decreased appetite—Gabapentin—epilepsy syndrome	7.25e-05	0.00053	CcSEcCtD
Lapatinib—Asthenia—Valproic Acid—epilepsy syndrome	7.22e-05	0.000528	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	7.2e-05	0.000527	CcSEcCtD
Lapatinib—Fatigue—Gabapentin—epilepsy syndrome	7.19e-05	0.000526	CcSEcCtD
Lapatinib—Abdominal pain—Pregabalin—epilepsy syndrome	7.19e-05	0.000526	CcSEcCtD
Lapatinib—Constipation—Gabapentin—epilepsy syndrome	7.13e-05	0.000522	CcSEcCtD
Lapatinib—Pruritus—Valproic Acid—epilepsy syndrome	7.12e-05	0.000521	CcSEcCtD
Lapatinib—Infection—Topiramate—epilepsy syndrome	6.97e-05	0.00051	CcSEcCtD
Lapatinib—Diarrhoea—Valproic Acid—epilepsy syndrome	6.88e-05	0.000504	CcSEcCtD
Lapatinib—Nervous system disorder—Topiramate—epilepsy syndrome	6.88e-05	0.000503	CcSEcCtD
Lapatinib—Gastrointestinal pain—Gabapentin—epilepsy syndrome	6.82e-05	0.000499	CcSEcCtD
Lapatinib—Skin disorder—Topiramate—epilepsy syndrome	6.82e-05	0.000499	CcSEcCtD
Lapatinib—Hypersensitivity—Pregabalin—epilepsy syndrome	6.7e-05	0.00049	CcSEcCtD
Lapatinib—Anorexia—Topiramate—epilepsy syndrome	6.69e-05	0.000489	CcSEcCtD
Lapatinib—Abdominal pain—Gabapentin—epilepsy syndrome	6.59e-05	0.000482	CcSEcCtD
Lapatinib—Asthenia—Pregabalin—epilepsy syndrome	6.53e-05	0.000477	CcSEcCtD
Lapatinib—Pruritus—Pregabalin—epilepsy syndrome	6.44e-05	0.000471	CcSEcCtD
Lapatinib—Vomiting—Valproic Acid—epilepsy syndrome	6.4e-05	0.000468	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	6.39e-05	0.000468	CcSEcCtD
Lapatinib—Insomnia—Topiramate—epilepsy syndrome	6.35e-05	0.000464	CcSEcCtD
Lapatinib—Rash—Valproic Acid—epilepsy syndrome	6.34e-05	0.000464	CcSEcCtD
Lapatinib—Dermatitis—Valproic Acid—epilepsy syndrome	6.34e-05	0.000464	CcSEcCtD
Lapatinib—Headache—Valproic Acid—epilepsy syndrome	6.3e-05	0.000461	CcSEcCtD
Lapatinib—Dyspnoea—Topiramate—epilepsy syndrome	6.26e-05	0.000458	CcSEcCtD
Lapatinib—Diarrhoea—Pregabalin—epilepsy syndrome	6.22e-05	0.000455	CcSEcCtD
Lapatinib—Dyspepsia—Topiramate—epilepsy syndrome	6.18e-05	0.000452	CcSEcCtD
Lapatinib—Hypersensitivity—Gabapentin—epilepsy syndrome	6.14e-05	0.000449	CcSEcCtD
Lapatinib—Decreased appetite—Topiramate—epilepsy syndrome	6.1e-05	0.000446	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Topiramate—epilepsy syndrome	6.06e-05	0.000443	CcSEcCtD
Lapatinib—Fatigue—Topiramate—epilepsy syndrome	6.05e-05	0.000443	CcSEcCtD
Lapatinib—Constipation—Topiramate—epilepsy syndrome	6e-05	0.000439	CcSEcCtD
Lapatinib—Asthenia—Gabapentin—epilepsy syndrome	5.98e-05	0.000438	CcSEcCtD
Lapatinib—Nausea—Valproic Acid—epilepsy syndrome	5.98e-05	0.000437	CcSEcCtD
Lapatinib—Pruritus—Gabapentin—epilepsy syndrome	5.9e-05	0.000432	CcSEcCtD
Lapatinib—Vomiting—Pregabalin—epilepsy syndrome	5.78e-05	0.000423	CcSEcCtD
Lapatinib—Gastrointestinal pain—Topiramate—epilepsy syndrome	5.74e-05	0.00042	CcSEcCtD
Lapatinib—Rash—Pregabalin—epilepsy syndrome	5.73e-05	0.00042	CcSEcCtD
Lapatinib—Dermatitis—Pregabalin—epilepsy syndrome	5.73e-05	0.000419	CcSEcCtD
Lapatinib—Diarrhoea—Gabapentin—epilepsy syndrome	5.71e-05	0.000417	CcSEcCtD
Lapatinib—Headache—Pregabalin—epilepsy syndrome	5.7e-05	0.000417	CcSEcCtD
Lapatinib—Abdominal pain—Topiramate—epilepsy syndrome	5.55e-05	0.000406	CcSEcCtD
Lapatinib—Nausea—Pregabalin—epilepsy syndrome	5.4e-05	0.000395	CcSEcCtD
Lapatinib—Vomiting—Gabapentin—epilepsy syndrome	5.3e-05	0.000388	CcSEcCtD
Lapatinib—Rash—Gabapentin—epilepsy syndrome	5.26e-05	0.000385	CcSEcCtD
Lapatinib—Dermatitis—Gabapentin—epilepsy syndrome	5.25e-05	0.000384	CcSEcCtD
Lapatinib—Headache—Gabapentin—epilepsy syndrome	5.22e-05	0.000382	CcSEcCtD
Lapatinib—Hypersensitivity—Topiramate—epilepsy syndrome	5.17e-05	0.000378	CcSEcCtD
Lapatinib—Asthenia—Topiramate—epilepsy syndrome	5.03e-05	0.000368	CcSEcCtD
Lapatinib—Pruritus—Topiramate—epilepsy syndrome	4.96e-05	0.000363	CcSEcCtD
Lapatinib—Nausea—Gabapentin—epilepsy syndrome	4.95e-05	0.000362	CcSEcCtD
Lapatinib—Diarrhoea—Topiramate—epilepsy syndrome	4.8e-05	0.000351	CcSEcCtD
Lapatinib—Vomiting—Topiramate—epilepsy syndrome	4.46e-05	0.000326	CcSEcCtD
Lapatinib—Rash—Topiramate—epilepsy syndrome	4.42e-05	0.000324	CcSEcCtD
Lapatinib—Dermatitis—Topiramate—epilepsy syndrome	4.42e-05	0.000323	CcSEcCtD
Lapatinib—Headache—Topiramate—epilepsy syndrome	4.4e-05	0.000322	CcSEcCtD
Lapatinib—Nausea—Topiramate—epilepsy syndrome	4.17e-05	0.000305	CcSEcCtD
Lapatinib—CYP2C8—Metabolism—KCNJ11—epilepsy syndrome	4.45e-06	3.88e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CHRM3—epilepsy syndrome	4.45e-06	3.88e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—FYN—epilepsy syndrome	4.43e-06	3.86e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	4.41e-06	3.85e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—H2AFX—epilepsy syndrome	4.41e-06	3.85e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—DUSP6—epilepsy syndrome	4.41e-06	3.85e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—AQP1—epilepsy syndrome	4.39e-06	3.83e-05	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	4.38e-06	3.83e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	4.36e-06	3.8e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	4.36e-06	3.8e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	4.36e-06	3.8e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PFKL—epilepsy syndrome	4.36e-06	3.8e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	4.36e-06	3.8e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—ADRA2A—epilepsy syndrome	4.35e-06	3.8e-05	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—SRC—epilepsy syndrome	4.35e-06	3.79e-05	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	4.34e-06	3.79e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—PLAT—epilepsy syndrome	4.33e-06	3.78e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—AQP1—epilepsy syndrome	4.28e-06	3.74e-05	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—JUN—epilepsy syndrome	4.28e-06	3.73e-05	CbGpPWpGaD
Lapatinib—ERBB2—Disease—SRC—epilepsy syndrome	4.27e-06	3.72e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—YWHAZ—epilepsy syndrome	4.26e-06	3.71e-05	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—VEGFA—epilepsy syndrome	4.23e-06	3.69e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	4.21e-06	3.68e-05	CbGpPWpGaD
Lapatinib—ERBB4—Disease—SRC—epilepsy syndrome	4.2e-06	3.67e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—ABCG2—epilepsy syndrome	4.18e-06	3.65e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CXCL12—epilepsy syndrome	4.18e-06	3.65e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—BDKRB2—epilepsy syndrome	4.18e-06	3.65e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—AKT1—epilepsy syndrome	4.18e-06	3.65e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—PRKCB—epilepsy syndrome	4.16e-06	3.63e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—IL6ST—epilepsy syndrome	4.15e-06	3.62e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.14e-06	3.61e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CRP—epilepsy syndrome	4.12e-06	3.6e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—TSC2—epilepsy syndrome	4.12e-06	3.6e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CNR1—epilepsy syndrome	4.11e-06	3.58e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—JUNB—epilepsy syndrome	4.11e-06	3.58e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—FGF2—epilepsy syndrome	4.1e-06	3.58e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—CCR5—epilepsy syndrome	4.09e-06	3.57e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—PLCB1—epilepsy syndrome	4.09e-06	3.57e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—CYP2C19—epilepsy syndrome	4.08e-06	3.56e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.06e-06	3.54e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—CYP11A1—epilepsy syndrome	4.05e-06	3.54e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—FGF2—epilepsy syndrome	4.04e-06	3.52e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—HTR7—epilepsy syndrome	4e-06	3.49e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—UPB1—epilepsy syndrome	3.98e-06	3.48e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ATIC—epilepsy syndrome	3.98e-06	3.48e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—NEU1—epilepsy syndrome	3.98e-06	3.48e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	3.97e-06	3.46e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	3.97e-06	3.46e-05	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	3.92e-06	3.42e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—HBEGF—epilepsy syndrome	3.89e-06	3.39e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CHRM3—epilepsy syndrome	3.87e-06	3.38e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	3.87e-06	3.38e-05	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—SRC—epilepsy syndrome	3.84e-06	3.35e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	3.83e-06	3.35e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—AKT3—epilepsy syndrome	3.82e-06	3.33e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—TSC2—epilepsy syndrome	3.81e-06	3.32e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—RELA—epilepsy syndrome	3.8e-06	3.32e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—PRKCB—epilepsy syndrome	3.8e-06	3.32e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—POMC—epilepsy syndrome	3.79e-06	3.31e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL6ST—epilepsy syndrome	3.79e-06	3.31e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—RELA—epilepsy syndrome	3.75e-06	3.27e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—MTOR—epilepsy syndrome	3.73e-06	3.25e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—ADAM10—epilepsy syndrome	3.73e-06	3.25e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—APOE—epilepsy syndrome	3.72e-06	3.25e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—CCL2—epilepsy syndrome	3.71e-06	3.24e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GBE1—epilepsy syndrome	3.7e-06	3.23e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	3.7e-06	3.23e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.7e-06	3.23e-05	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—SRC—epilepsy syndrome	3.69e-06	3.22e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—MTOR—epilepsy syndrome	3.67e-06	3.21e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—CYP2D6—epilepsy syndrome	3.66e-06	3.19e-05	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—TNF—epilepsy syndrome	3.63e-06	3.16e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—ABCG2—epilepsy syndrome	3.62e-06	3.16e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.62e-06	3.16e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CYP2C19—epilepsy syndrome	3.53e-06	3.08e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—S100B—epilepsy syndrome	3.52e-06	3.08e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CYP11A1—epilepsy syndrome	3.51e-06	3.06e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—IL6ST—epilepsy syndrome	3.5e-06	3.05e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—SOCS3—epilepsy syndrome	3.49e-06	3.05e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.49e-06	3.04e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	3.48e-06	3.04e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—ADRA2A—epilepsy syndrome	3.48e-06	3.04e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CDC42—epilepsy syndrome	3.48e-06	3.04e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—FOS—epilepsy syndrome	3.47e-06	3.03e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—NOS2—epilepsy syndrome	3.47e-06	3.03e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—BCHE—epilepsy syndrome	3.47e-06	3.03e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CASP3—epilepsy syndrome	3.43e-06	2.99e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CASP8—epilepsy syndrome	3.39e-06	2.96e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	3.39e-06	2.96e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CASP3—epilepsy syndrome	3.38e-06	2.95e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—AVP—epilepsy syndrome	3.37e-06	2.94e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—JUN—epilepsy syndrome	3.33e-06	2.91e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—SLC2A1—epilepsy syndrome	3.31e-06	2.89e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ALAD—epilepsy syndrome	3.3e-06	2.88e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—NT5E—epilepsy syndrome	3.3e-06	2.88e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—JUN—epilepsy syndrome	3.28e-06	2.86e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PLCB1—epilepsy syndrome	3.27e-06	2.86e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—TH—epilepsy syndrome	3.26e-06	2.84e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—MMP9—epilepsy syndrome	3.24e-06	2.83e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	3.24e-06	2.82e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—MMP9—epilepsy syndrome	3.19e-06	2.79e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—HES1—epilepsy syndrome	3.19e-06	2.78e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.18e-06	2.77e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CYP2D6—epilepsy syndrome	3.17e-06	2.76e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—ABCG2—epilepsy syndrome	3.16e-06	2.76e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	3.15e-06	2.75e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	3.15e-06	2.75e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	3.13e-06	2.73e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.11e-06	2.71e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—FYN—epilepsy syndrome	3.1e-06	2.7e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—H2AFX—epilepsy syndrome	3.09e-06	2.7e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—MEF2C—epilepsy syndrome	3.08e-06	2.69e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	3.08e-06	2.69e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	3.08e-06	2.69e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—FGF2—epilepsy syndrome	3.06e-06	2.67e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	3.06e-06	2.67e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ADSL—epilepsy syndrome	3.02e-06	2.63e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	3.02e-06	2.63e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—BCHE—epilepsy syndrome	3e-06	2.62e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—SRC—epilepsy syndrome	2.99e-06	2.61e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—YWHAZ—epilepsy syndrome	2.98e-06	2.6e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GLUL—epilepsy syndrome	2.96e-06	2.58e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—NGF—epilepsy syndrome	2.95e-06	2.57e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—SRC—epilepsy syndrome	2.94e-06	2.57e-05	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	2.91e-06	2.54e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—VEGFA—epilepsy syndrome	2.91e-06	2.54e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—BCL2—epilepsy syndrome	2.91e-06	2.54e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	2.91e-06	2.54e-05	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—AKT1—epilepsy syndrome	2.87e-06	2.51e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—VEGFA—epilepsy syndrome	2.87e-06	2.5e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CCR5—epilepsy syndrome	2.87e-06	2.5e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	2.87e-06	2.5e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—RELA—epilepsy syndrome	2.84e-06	2.48e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.84e-06	2.47e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	2.83e-06	2.47e-05	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—AKT1—epilepsy syndrome	2.83e-06	2.47e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—FGF2—epilepsy syndrome	2.83e-06	2.47e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	2.83e-06	2.47e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—TH—epilepsy syndrome	2.82e-06	2.46e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—HTR2A—epilepsy syndrome	2.81e-06	2.45e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—MTOR—epilepsy syndrome	2.79e-06	2.43e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.78e-06	2.43e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	2.76e-06	2.41e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	2.72e-06	2.37e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	2.72e-06	2.37e-05	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—AKT1—epilepsy syndrome	2.7e-06	2.36e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	2.69e-06	2.35e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—CAT—epilepsy syndrome	2.68e-06	2.34e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—BCHE—epilepsy syndrome	2.68e-06	2.34e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TSC2—epilepsy syndrome	2.66e-06	2.33e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—AGT—epilepsy syndrome	2.66e-06	2.32e-05	CbGpPWpGaD
Lapatinib—ERBB2—Disease—AKT1—epilepsy syndrome	2.65e-06	2.31e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—AQP1—epilepsy syndrome	2.64e-06	2.3e-05	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.63e-06	2.3e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	2.63e-06	2.29e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—BCHE—epilepsy syndrome	2.62e-06	2.28e-05	CbGpPWpGaD
Lapatinib—ERBB4—Disease—AKT1—epilepsy syndrome	2.61e-06	2.28e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	2.61e-06	2.28e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—APOE—epilepsy syndrome	2.61e-06	2.28e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—MTOR—epilepsy syndrome	2.58e-06	2.25e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL1B—epilepsy syndrome	2.57e-06	2.24e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	2.56e-06	2.23e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—KDR—epilepsy syndrome	2.55e-06	2.23e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—PTGS2—epilepsy syndrome	2.55e-06	2.23e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	2.53e-06	2.21e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—TH—epilepsy syndrome	2.52e-06	2.2e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	2.5e-06	2.18e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—JUN—epilepsy syndrome	2.49e-06	2.17e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.48e-06	2.17e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PLCB1—epilepsy syndrome	2.47e-06	2.15e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—TH—epilepsy syndrome	2.46e-06	2.15e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—PRKCB—epilepsy syndrome	2.46e-06	2.15e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IL6ST—epilepsy syndrome	2.45e-06	2.14e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—GPX1—epilepsy syndrome	2.43e-06	2.12e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	2.39e-06	2.08e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	2.39e-06	2.08e-05	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—AKT1—epilepsy syndrome	2.38e-06	2.08e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	2.36e-06	2.06e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CAT—epilepsy syndrome	2.33e-06	2.03e-05	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—AKT1—epilepsy syndrome	2.29e-06	2e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	2.26e-06	1.97e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—POMC—epilepsy syndrome	2.24e-06	1.95e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—SRC—epilepsy syndrome	2.24e-06	1.95e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CCL2—epilepsy syndrome	2.19e-06	1.91e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—AGT—epilepsy syndrome	2.13e-06	1.86e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	2.1e-06	1.84e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—GPX1—epilepsy syndrome	2.1e-06	1.84e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—APOE—epilepsy syndrome	2.09e-06	1.82e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CAT—epilepsy syndrome	2.08e-06	1.81e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—SRC—epilepsy syndrome	2.06e-06	1.8e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—HMOX1—epilepsy syndrome	2.05e-06	1.79e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CAT—epilepsy syndrome	2.03e-06	1.77e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	2.02e-06	1.76e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—FGF2—epilepsy syndrome	1.98e-06	1.73e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.95e-06	1.7e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.9e-06	1.65e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.88e-06	1.64e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—GPX1—epilepsy syndrome	1.88e-06	1.64e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—AKT1—epilepsy syndrome	1.86e-06	1.62e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—AGT—epilepsy syndrome	1.84e-06	1.61e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—RELA—epilepsy syndrome	1.84e-06	1.6e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—GPX1—epilepsy syndrome	1.83e-06	1.6e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—AKT1—epilepsy syndrome	1.83e-06	1.6e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—APOE—epilepsy syndrome	1.81e-06	1.58e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—MTOR—epilepsy syndrome	1.8e-06	1.57e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—POMC—epilepsy syndrome	1.79e-06	1.56e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.7e-06	1.48e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CASP3—epilepsy syndrome	1.66e-06	1.45e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—AGT—epilepsy syndrome	1.65e-06	1.44e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—ALB—epilepsy syndrome	1.63e-06	1.43e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.62e-06	1.41e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—APOE—epilepsy syndrome	1.61e-06	1.41e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.61e-06	1.41e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—JUN—epilepsy syndrome	1.61e-06	1.41e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—AGT—epilepsy syndrome	1.61e-06	1.4e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—APOE—epilepsy syndrome	1.57e-06	1.37e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—MMP9—epilepsy syndrome	1.57e-06	1.37e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—POMC—epilepsy syndrome	1.55e-06	1.35e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.54e-06	1.34e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.52e-06	1.33e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—AKT1—epilepsy syndrome	1.52e-06	1.33e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—TH—epilepsy syndrome	1.52e-06	1.32e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—SRC—epilepsy syndrome	1.45e-06	1.26e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	1.43e-06	1.25e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—ALB—epilepsy syndrome	1.42e-06	1.23e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—VEGFA—epilepsy syndrome	1.41e-06	1.23e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—AKT1—epilepsy syndrome	1.39e-06	1.21e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—POMC—epilepsy syndrome	1.39e-06	1.21e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—POMC—epilepsy syndrome	1.35e-06	1.18e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—AKT1—epilepsy syndrome	1.28e-06	1.12e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.27e-06	1.1e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—ALB—epilepsy syndrome	1.26e-06	1.1e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.25e-06	1.09e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	1.24e-06	1.08e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—ALB—epilepsy syndrome	1.23e-06	1.08e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.21e-06	1.06e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.13e-06	9.85e-06	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	1.11e-06	9.64e-06	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PTGS2—epilepsy syndrome	1.08e-06	9.41e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—AGT—epilepsy syndrome	9.9e-07	8.64e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—APOE—epilepsy syndrome	9.7e-07	8.46e-06	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—AKT1—epilepsy syndrome	8.98e-07	7.84e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—POMC—epilepsy syndrome	8.33e-07	7.27e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ALB—epilepsy syndrome	7.6e-07	6.63e-06	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—AKT1—epilepsy syndrome	7.18e-07	6.27e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	6.65e-07	5.8e-06	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—AKT1—epilepsy syndrome	6.22e-07	5.43e-06	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—AKT1—epilepsy syndrome	5.55e-07	4.85e-06	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—AKT1—epilepsy syndrome	5.42e-07	4.73e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—AKT1—epilepsy syndrome	3.34e-07	2.91e-06	CbGpPWpGaD
